Sign In

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.


Transnational BIOMAT-In cooperation project launched
European tool enables companies to open up markets

(Stuttgart) - BioRegio STERN Management GmbH is one of five project partners
in BIOMAT-In. This transnational EU project promotes innovations and
cooperation in the biomaterials sector and is being funded for three years
with a total of EUR 1.24 million. BioRegio STERN Management GmbH is
committed to creating a successful pan-European cluster in regenerative
medicine and tissue engineering. It is receiving EUR 223,000 during this
period to develop a sustainable network of companies, institutions and

Biomaterials are already used in a large number of medical areas. Contact
lenses, dentures, heart valves and artificial hip joints are all items that
form an interface between synthetically produced materials and the human
biological system. The potential for innovations in this field of research
is immense, with a constant influx of new findings from sectors such as
material sciences, electronics and nanotechnology.

From an interdisciplinary research perspective, developing a transnational
network of all players in the biomaterials sector, i.e. industry, research,
hospitals and companies, is vital. Together with four other European
leading-edge clusters from France, the Netherlands and the UK, the STERN
BioRegion will in future be promoting innovations in this area as part of
the BIOMAT-In project. Unique expertise in regenerative medicine and tissue
engineering is already concentrated in the STERN BioRegion. Numerous
research institutes, hospitals and companies work here intensively on
medical applications in areas such as skin and wound treatment and
cardiovascular disease.

These findings and data from the cooperating clusters will be pooled into a
database over the next three years, giving entrepreneurs an overview of the
entire European network together with key information on the relevant
approval procedures and market opportunities. The project will be
accompanied by a range of events and network activities. For instance,
matchmaking events will bring together research institutes and companies
from the various regions for development and production projects and a
voucher system will also provide incentives for transnational cooperation.
The project has a budget totalling EUR 1.24 million, of which EUR 223,000 is
available to BioRegio STERN Management GmbH.

European cooperation projects such as BIOMAT-In are necessary and useful,
says project manager Dr. Manfred Kauer. 'Healthcare markets are national and
highly regulated. Companies looking to operate across national borders still
have to collate the approval procedures and market opportunities in the
respective countries. BIOMAT-In will provide all the key information at the
touch of a button, enabling our export-oriented companies to open up
international markets.'
For further information on the BIOMAT-In project, go to

About BioRegio STERN:
For ten years, BioRegio STERN Management GmbH has been a skill-sharing
network in the cities of Stuttgart, Tübingen, Esslingen, and Reutlingen and
the Neckar-Alb and Stuttgart regions in the Baden-Württemberg area of
Germany, providing a source of help and advice for founders of new
businesses, entrepreneurs and researchers from the biotechnology sector.
BioRegio STERN Management GmbH represents their interests in dealings with
politicians, the media and associations. It offers business promotion and
marketing services and provides advice on grant applications and corporate
financing. Regenerative medicine, medical technology and the automation of
biotechnology are key focal points. The Managing Director, Dr. Klaus
Eichenberg, is a molecular and cell biologist and investment analyst.

About BIOMAT-In:
The EU BIOMAT-In project encourages new business relationships between small
and medium-sized enterprises and research institutes in biomaterials and
tissue engineering. The project is supported by five leading European
clusters - Eurasanté and Atlanpole Biotherapies in France, the STERN
Bioregion in Germany, LIOF in the Netherlands and Medilink East Midlands in
the UK.
Launched in March 2011, the project will run for three years and has a
budget of EUR 1.24 million. It is part funded by the European Regional
Development Fund (ERDF) as part of the Interreg IVB North-West Europe
The contact in Germany is Dr. Manfred Kauer of BioRegio STERN Management
GmbH. Contact: or tel. +49 (0)711-870354-26.

Publisher: BioRegio STERN Management GmbH
Friedrichstrasse 10, 70174 Stuttgart, Germany, +49-711-8703540,
Editor: Zeeb Kommunikation GmbH,
Hohenheimer Strasse 58a, 70184 Stuttgart, Germany, +49-711-6070719,

Publisher Contact Information:

BioRegio STERN Management

Company profile of BioRegio STERN Management
Past press releases of BioRegio STERN Management.


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Nov 25€24.0MInternet commerce
Feb 14€19.0MBiopharmaceuticals
Feb 14N/AInternet services
Feb 14€4.6MBusiness applications
Feb 13€13.0MBiopharmaceuticals
Feb 13€25.0MMedical devices
Feb 13€15.0MBusiness applications

For information on Europe's most extensive database on technology funding click here!


Press Releases

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Jan 29
yumpingo raises $10m to transform guest experiences in restaurants

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.